Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Longitudinal changes in pancreatic neuroendocrine tumor (panNET) cell proliferation correlate with fast disease progression and poor prognosis. The optimal treatment strategy for secondary panNET grade (G)3 that has progressed from a previous low-or intermediate-grade to high-grade panNET G3 is curr...

Full description

Bibliographic Details
Main Authors:	Kazhan Mollazadegan, Britt Skogseid, Johan Botling, Tobias Åkerström, Barbro Eriksson, Staffan Welin, Anders Sundin, Joakim Crona
Format:	Article
Language:	English
Published:	Bioscientifica 2022-03-01
Series:	Endocrine Connections
Subjects:	pancreatic neuroendocrine tumor highgrade systemic therapy treatment outcomes
Online Access:	https://ec.bioscientifica.com/view/journals/ec/11/3/EC-21-0604.xml

Similar Items

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
by: Lovisa Falkman, et al.
Published: (2024-04-01)

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE
by: Olof Joakim Pettersson, et al.
Published: (2021-04-01)

Retrospective analysis of functional and anatomical changes, the level of intraocular pressure in patients with glaucoma and highgrade myopia during surgical treatment of cataracts
by: O. V. Krasnozhan, et al.
Published: (2021-07-01)

Predicting Factor for Occurrence of Postoperative Pancreatic Fistula in Patients with Pancreatic Neuroendocrine Tumors
by: Nutu Vlad, et al.
Published: (2025-01-01)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
by: Michele Bevere, et al.
Published: (2023-01-01)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
by: He-Li Gao, et al.
Published: (2020-10-01)

Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
by: Jasmeet Kaur, et al.
Published: (2023-09-01)

Surgical management of pancreatic neuroendocrine neoplasms
by: Piero Alberti, et al.
Published: (2023-09-01)

The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)
by: Yongkang Liu, et al.
Published: (2023-12-01)

Incidental intraoperative discovery of a pancreatic neuroendocrine tumor associated with chronic pancreatitis
by: Surlin Valeriu, et al.
Published: (2012-09-01)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
by: Marcos BELOTTO, et al.
Published: (2019-02-01)

Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms
by: Tatsuya Ishii, et al.
Published: (2021-02-01)

Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology
by: Xu Han, et al.
Published: (2018-02-01)

Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
by: Haihong Wang, et al.
Published: (2020-03-01)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
by: Sumana Devata, et al.
Published: (2012-11-01)

Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
by: Alessandra Pulvirenti, et al.
Published: (2020-08-01)

Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single-center experience
by: Shu-Jie Ren, et al.
Published: (2023-02-01)

Contrast-Enhanced Harmonic Endoscopic Ultrasound for Diagnosis of the Aggressiveness of Pancreatic Neuroendocrine Neoplasm
by: Takashi Tamura, et al.
Published: (2022-11-01)

A CT-based diagnostic nomogram and survival analysis for differentiating grade 3 pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas
by: Miaomiao Hu, et al.
Published: (2024-08-01)

Radiological Variability in Pancreatic Neuroendocrine Neoplasms: A 10-Year Single-Center Study on Atypical Presentations and Diagnostic Challenges
by: Eleanor Danek, et al.
Published: (2025-02-01)

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms
by: Zhijiang Chen, et al.
Published: (2024-10-01)

Pancreatic Divisum Associated with Ampullary Neuroendocrine Tumor and the Role of Magnetic Resonance Imaging
by: Fatma Kulalı, et al.
Published: (2017-09-01)

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
by: Martine Bocchini, et al.
Published: (2020-05-01)

Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms
by: Max B. Albers, et al.
Published: (2024-08-01)

A single-center experience with pancreatic cystic neuroendocrine tumors
by: Ange Khalil, et al.
Published: (2020-08-01)

Hypovascular pancreatic neuroendocrine tumor with hepatic metastases: A case report and literature review
by: Ngo-Van Doan, MD, et al.
Published: (2021-06-01)

Chinese interpretation of European Neuroendocrine Tumour Society 2023 guidance for nonfunctioning pancreatic neuroendocrine tumours
by: HAN Liang, LIU Haonan, WU Zheng
Published: (2024-01-01)

Pancreatic Neuroendocrine Tumor Presenting as Acute Pancreatitis
by: Minjeong Kim, et al.
Published: (2018-02-01)

A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1
by: Nishi Takeshi, et al.
Published: (2012-07-01)

Pancreatic neuroendocrine carcinoma with unique morphological features mimicking intraductal papillary mucinous carcinoma: A case report
by: Hidekazu Tanaka, et al.
Published: (2022-07-01)

Outcomes after Surgery for Malignant Pancreatic Neuroendocrine Tumors
by: Omar Hama Ghalib Azeez Hawramy, et al.
Published: (2019-08-01)

Evolution in the surgical treatment concepts of pancreatic neuroendocrine tumors
by: WANG Xianze, WU Wenming
Published: (2022-09-01)

The rare case of a cystic pancreatic neuroendocrine tumor
by: Tarun Kumar, et al.
Published: (2021-09-01)

Unilateral pseudouveitis revealing a pancreatic neuroendocrine carcinoma: A case report
by: Faten Cherchir, et al.
Published: (2022-03-01)

Diagnostic Value of Peripheral Blood NLR and PLR in Gastrointestinal Pancreatic Neuroendocrine Neoplasm
by: ZHAO Ran, et al.
Published: (2019-08-01)

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
by: Zheng Zhang, et al.
Published: (2022-05-01)

Case of an abnormal procalcitonin‐producing metastatic pancreatic neuroendocrine tumor
by: Wei‐Zhen Wang, et al.
Published: (2020-11-01)

Pancreatic neuroendocrine tumor with stenosis of the main pancreatic duct leading to pancreatic pleural effusion: a case report
by: Yuta Yoshida, et al.
Published: (2020-09-01)

CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
by: Yanqi Zhong, et al.
Published: (2023-01-01)

Early-onset pancreatic neuroendocrine neoplasms: A distinct disease with improved survival compared with old individuals
by: Zhen Yang, et al.
Published: (2023-04-01)